Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E є4 in Alzheimer’s Disease

References

• World Health Organization. Pages. http://www.who.int/mediacentre/factsheets/fs362/en/. 2016. Accessed March 23, 2017.
   Google Scholar
• Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186–191. doi:10.1016/j.jalz.2007.04.381.
   PubMed Web of Science ®Google Scholar
• Perl DP. Neuropathology of Alzheimer's disease. Mt Sinai J Med. 2010;77(1):32–42. doi:10.1002/msj.20157.
   PubMedGoogle Scholar
• Takizawa C, Thompson PL, van Walsem A, Faure C, Maier WC. Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America. JAD. 2015;43(4):1271–1284. doi:10.3233/JAD-141134.
   Google Scholar
• Harrington CR. The molecular pathology of Alzheimer's disease. Neuroimaging Clin N Am. 2012;22(1):11–22, vii. doi:10.1016/j.nic.2011.11.003.
   PubMed Web of Science ®Google Scholar
• Willette AA, Bendlin BB, Starks EJ, et al. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol. 2015;72(9):1013–1020. doi:10.1001/jamaneurol.2015.0613.
   PubMed Web of Science ®Google Scholar
• Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18(5):421–430. doi:10.1038/gim.2015.117.
   PubMed Web of Science ®Google Scholar
• Xu W, Tan L, Wang H-F, et al. Meta-analysis of modifiable risk factors for Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299. doi:10.1136/jnnp-2015-310548.
   PubMed Web of Science ®Google Scholar
• Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492–498. doi:10.1002/ana.21509.
   PubMed Web of Science ®Google Scholar
• Lopes da Silva S, Vellas B, Elemans S, et al. Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimers Dement. 2014;10(4):485–502. doi:10.1016/j.jalz.2013.05.1771.
   PubMed Web of Science ®Google Scholar
• Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627–635. doi:10.1093/ajcn/82.3.627.
   PubMed Web of Science ®Google Scholar
• Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging. 2002;6(1):39–42.
   PubMedGoogle Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):6. doi:10.1186/1475-2891-14-6.
   PubMed Web of Science ®Google Scholar
• Persichilli S, Gervasoni J, Di Napoli A, et al. Plasma thiols levels in Alzheimer's disease mice under diet-induced hyperhomocysteinemia: effect of S-adenosylmethionine and superoxide-dismutase supplementation. JAD. 2015;44(4):1323–1331. doi:10.3233/JAD-142391.
   Google Scholar
• Pietrzik K, Bronstrup A. Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population. Eur J Pediatr. 1998;157 (Suppl 2):S135–S138. doi:10.1007/PL00014298.
   PubMedGoogle Scholar
• Shen L, Ji HF. Associations between homocysteine, folic acid, vitamin B12 and Alzheimer's disease: insights from meta-analyses. JAD. 2015;46(3):777–790. doi:10.3233/JAD-150140.
   Google Scholar
• Minagawa H, Watanabe A, Akatsu H, et al. Homocysteine, another risk factor for Alzheimer disease, impairs Apolipoprotein E3 function. J Biol Chem. 2010;285(49):38382–38388. doi:10.1074/jbc.M110.146258.
   PubMed Web of Science ®Google Scholar
• Yoshinaga T, Nishimata H, Kajiya Y, Yokoyama S. Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid β accumulation. PLoS One. 2017;12(4):e0175854. doi:10.1371/journal.pone.0175854.
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636–643. doi:10.1093/ajcn.82.3.636.
   PubMed Web of Science ®Google Scholar
• Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346(7):476–483. doi:10.1056/NEJMoa011613.
   PubMed Web of Science ®Google Scholar
• D'Cunha NM, Georgousopoulou EN, Dadigamuwage L, et al. Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials. Br J Nutr. 2018;119(3):280298. doi:10.1017/S0007114517003452.
   Web of Science ®Google Scholar
• Smith AD, de Jager CA, Refsum H, Rosenberg IH. Homocysteine lowering, B vitamins, and cognitive aging. Am J Clin Nutr. 2015;101(2):415–416. doi:10.3945/ajcn.114.098467.
   PubMed Web of Science ®Google Scholar
• Beckett EL, Martin C, Boyd L, et al. Reduced plasma homocysteine levels in elderly Australians following mandatory folic acid fortification: a comparison of two cross-sectional cohorts. J Nutr Intermed Metab. 2017;8:14–20. doi:10.1016/j.jnim.2017.04.001.
   Google Scholar
• Liu C-C, Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106–118. doi:10.1038/nrneurol.2012.263.
   PubMed Web of Science ®Google Scholar
• Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278(16):1349–1356.
   PubMed Web of Science ®Google Scholar
• Nebel A, Kleindorp R, Caliebe A, et al. A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev. 2011;132(6–7):324–330. doi:10.1016/j.mad.2011.06.008.
   PubMed Web of Science ®Google Scholar
• Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Plasma levels of Apolipoprotein E and risk of dementia in the general population. Ann Neurol. 2015;77(2):301–311. doi:10.1002/ana.24326.
   PubMed Web of Science ®Google Scholar
• Teng E, Chow N, Hwang KS, et al. Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. Dement Geriatr Cogn Disord. 2015;39(3–4):154–166. doi:10.1159/000368982.
   PubMed Web of Science ®Google Scholar
• Martínez-Lapiscina EH, Galbete C, Corella D, et al. Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial. Genes Nutr. 2014;9(3):393. doi:10.1007/s12263-014-0393-7.
   PubMed Web of Science ®Google Scholar
• Gardener SL, Rainey-Smith SR, Barnes MB, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Mol Psychiatry. 2015;20(7):860–866. doi:10.1038/mp.2014.79.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol. 2002;59(8):1258–1263. doi:10.1001/archneur.59.8.1258.
   PubMedGoogle Scholar
• Lane-Donovan C, Herz J. High-fat diet changes hippocampal Apolipoprotein E (ApoE) in a genotype- and carbohydrate-dependent manner in mice. PLoS One. 2016;11(2):e0148099. doi:10.1371/journal.pone.0148099.
   PubMed Web of Science ®Google Scholar
• D’Cunha NM, McKune AJ, Panagiotakos DB, et al. Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease. Nutritional Neuroscience. 2019;22(1):1–18. doi:10.1080/1028415X.2017.1349032.
   PubMed Web of Science ®Google Scholar
• Troesch B, Weber P, Mohajeri MH. Potential links between impaired one-carbon metabolism due to polymorphisms, inadequate B-vitamin status, and the development of Alzheimer's disease. Nutrients. 2016;8(12):803. doi:10.3390/nu8120803.
   Web of Science ®Google Scholar
• Tai LM, Mehra S, Shete V, et al. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol Neurodegener. 2014;9:2. doi:10.1186/1750-1326-9-2.
   PubMed Web of Science ®Google Scholar
• Brown B, Huang M-H, Karlamangla A, Seeman T, Kado D. Do the effects of APOE- E4 on cognitive function and decline depend upon vitamin status? Macarthur studies of successful aging. J Nutr Health Aging. 2011;15(3):196–201. doi:10.1007/s12603-010-0277-5.
   PubMed Web of Science ®Google Scholar
• West RK, Beeri MS, Schmeidler J, et al. Homocysteine and cognitive function in very elderly nondemented subjects. Am J Geriatr Pharmacother. 2011;19(7):673–677. doi:10.1097/JGP.0b013e3181faee37.
   Google Scholar
• Bunce D, Kivipelto M, Wahlin A. Apolipoprotein E, B vitamins, and cognitive function in older adults. J Gerontol B Psychol Sci Soc Sci. 2005;60(1):P41–P48. doi:10.1093/geronb/60.1.P41.
   PubMed Web of Science ®Google Scholar
• Vogiatzoglou A, Smith AD, Nurk E, et al. Cognitive function in an elderly population: interaction between vitamin B12 status, depression, and Apolipoprotein E epsilon4: the Hordaland Homocysteine Study. Psychosom Med. 2013;75(1):20–29. doi:10.1097/PSY.0b013e3182761b6c.
   PubMed Web of Science ®Google Scholar
• Feng L, Li J, Yap KB, Kua EH, Ng TP. Vitamin B-12, Apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction. Am J Clin Nutr. 2009;89(4):1263–1268. doi:10.3945/ajcn.2008.26969.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6.
   PubMed Web of Science ®Google Scholar
• Naumovski N, Veysey M, Ng X, et al. The folic acid endophenotype and depression in an elderly population. J Nutr Health Aging. 2010;14(10):829–833. doi:10.1007/s12603-010-0135-5.
   PubMed Web of Science ®Google Scholar
• Dufficy L, Naumovski N, Ng X, et al. G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population. Life Sci. 2006;79(10):957–966. doi:10.1016/j.lfs.2006.05.009.
   PubMed Web of Science ®Google Scholar
• Ambrosini GL, Mackerras D, de Klerk NH, Musk AW. Comparison of an Australian food-frequency questionnaire with diet records: implications for nutrition surveillance. Public Health Nutr. 2003;6(4):415–422. doi:10.1079/PHN2002434.
   PubMed Web of Science ®Google Scholar
• Krijt J, Vacková M, Kožich V. Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with Tri-n-butylphosphine. Clin Chem. 2001;47(10):1821. doi:10.1126/science.3287615.
   PubMed Web of Science ®Google Scholar
• Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285–1293.
   PubMed Web of Science ®Google Scholar
• Cole TJ. Too many digits: the presentation of numerical data. Arch Dis Child. 2015;100(7):608. doi:10.1136/archdischild-2014-307149.
   PubMed Web of Science ®Google Scholar
• Chopra A, Cavalieri TA, Libon DJ. Dementia Screening Tools for the Primary Care Physician. John Hopkins Medicine Continuing Medical Education; 2007. New Jersey Institute for Successful Aging, University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine, Stratford, New Jersey, USA.
   Google Scholar
• Miwa K, Tanaka M, Okazaki S, et al. Increased total homocysteine levels predict the risk of incident dementia independent of cerebral small-vessel diseases and vascular risk factors. JAD. 2016;49(2):503–513. doi:10.3233/JAD-150458.
   Google Scholar
• Lee YM, Ha JK, Park JM, et al. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease. Psychogeriatrics. 2016;16(1):3–11. doi:10.1111/psyg.12109.
   PubMed Web of Science ®Google Scholar
• Religa D, Styczynska M, Peplonska B, et al. Homocysteine, Apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord. 2003;16(2):64–70. doi:10.1159/000070677.
   PubMed Web of Science ®Google Scholar
• Yang JG, Poropat RA, Brooks WS, Broe GA, Nicholson GA. Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample. Aust N Z J Med. 1996;26(5):658–661. doi:10.1111/j.1445-5994.1996.tb02936.x.
   PubMedGoogle Scholar
• Hopkins PCR, Huang Y, McGuire JG, Pitas RE. Evidence for differential effects of apoE3 and apoE4 on HDL metabolism. J Lipid Res. 2002;43(11):1881–1889. doi:10.1194/jlr.M200172-JLR200.
   PubMed Web of Science ®Google Scholar
• Trusca VG, Mihai AD, Fuior EV, Fenyo IM, Gafencu AV. High levels of homocysteine downregulate Apolipoprotein E expression via nuclear factor kappa B. WJBC. 2016;7(1):178–187. doi:10.4331/wjbc.v7.i1.178.
   Google Scholar
• Agnew-Blais JC, Wassertheil-Smoller S, Kang JH, et al. Folate, vitamin B6 and vitamin B12 intake and mild cognitive impairment and probable dementia in the Women’s Health Initiative Memory Study. J Acad Nutr Diet. 2015;115(2):231–241. doi:10.1016/j.jand.2014.07.006.
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Bienias JL, et al. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol. 2005;62(4):641–645. doi:10.1001/archneur.62.4.641.
   PubMedGoogle Scholar
• McCarty MF, DiNicolantonio JJ. An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly. Age (Dordr). 2015;37(5):96. doi:10.1007%2Fs11357-015-9823-8.
   PubMedGoogle Scholar
• Jones DS, Greene JA. Is dementia in decline? Historical trends and future trajectories. N Engl J Med. 2016;374(6):507–509. doi:10.1056/NEJMp1514434.
   PubMed Web of Science ®Google Scholar
• de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012;27(6):592–600. doi:10.1002/gps.2758.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu S, Ji L, et al. Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: a randomized controlled trial. Mediators Inflamm. 2016;2016:1. doi:10.1155/2016/5912146.
   Web of Science ®Google Scholar
• Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369(9557):208–216. doi:10.1016/S0140-6736(07)60109-3.
   PubMed Web of Science ®Google Scholar
• Moore EM, Ames D, Mander AG, et al. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. JAD. 2014;39(3):661–668. doi:10.3233/JAD-131265.
   Google Scholar
• Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26(10):2170–2183. doi:10.1002/sim.2677.
   PubMed Web of Science ®Google Scholar
• Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J Alzheimers Dis. 2016;50(2):547–557. doi:10.3233/JAD-150777.
   PubMed Web of Science ®Google Scholar
• Willett W. Food Frequency Methods; Chapter 6: Reproducibility and Validity of Food-Frequency Questionairres; Chapter 11: Implications of Total Energy Intake for Epidemiologic Analyses. Nutritional Epidemiology. 3rd ed. Oxford, England: Oxford University Press; 2012.
   Google Scholar